1067515

Regeneron Pharmaceuticals Inc — FEI 1000521995

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 10, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Tarrytown, NY (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)